Policy and Regulation · 29 September 2026 to 29 September 2026 · 1 headlines · STAT
STAT Plus: 5 burning questions on Trump’s latest deals with drugmakers
There are five key unresolved questions surrounding the Trump administration's latest deals with pharmaceutical companies.
As it ran
29 September 2026
More from US healthcare
- STAT Plus: England to cover AstraZeneca breast cancer drug, a result of U.K.-U.S. drug pricing deal 29 September 2026
- She’s spent two decades talking to parents who don’t vaccinate their children. Here’s what she’s learned 29 September 2026
- Trump's state Medicaid drug pricing deals 29 September 2026
- Confusion and Angst Follow State’s Early Rollout of Medicaid Work Rules 29 September 2026
- DreaMed Wins FDA Clearance for CGM-Driven Insulin Automation Tool for Both Type 2 Injection Regimens 29 September 2026
- What 340B rebates could mean for hospital cash, staffing, per CEOs 29 September 2026
- Trump's impoundment of congressional spending 28 September 2026
- 901 Dead in Outbreak; 8 Hospitalized After Cheese Consumption; New FDA Approvals 28 September 2026